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Background: Chronic diseases represent a major challenge for health care and social services. A number of people
with chronic diseases require more services due to characteristics that increase their vulnerability. Given the burden
of increasingly vulnerable patients on primary care, a pragmatic intervention in four Family Medicine Groups
(primary care practices in Quebec, Canada) has been proposed for individuals with chronic diseases (diabetes,
cardiovascular diseases, respiratory diseases, musculoskeletal diseases and/or chronic pain) who are frequent users
of hospital services. The intervention combines case management by a nurse with group support meetings
encouraging self-management based on the Stanford Chronic Disease Self-Management Program. The goals of this
study are to: (1) analyze the implementation of the intervention in the participating practices in order to determine
how the various contexts have influenced the implementation and the observed effects; (2) evaluate the proximal
(self-efficacy, self-management, health habits, activation and psychological distress) and intermediate
(empowerment, quality of life and health care use) effects of the intervention on patients; (3) conduct an economic
analysis of the efficiency and cost-effectiveness of the intervention.
Methods/Design: The analysis of the implementation will be conducted using realistic evaluation and participatory
approaches within four categories of stakeholders (Family Medicine Group and health centre management, Family
Medicine Group practitioners, patients and their families, health centre or community partners). The data will be
obtained through individual and group interviews, project documentation reviews and by documenting the
intervention. Evaluation of the effects on patients will be based on a pragmatic randomized before-after
experimental design with a delayed intervention control group (six months). Economic analysis will include
cost-effectiveness and cost-benefit analysis.
Discussion: The integration of a case management intervention delivered by nurses and self-management group
support into primary care practices has the potential to positively impact patient empowerment and quality of life
and hopefully reduce the burden on health care. Decision-makers, managers and health care professionals will be
aware of the factors to consider in promoting the implementation of this intervention into other primary care
practices in the region and elsewhere.
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Because of their high prevalence and significant effects,
chronic diseases (CD) pose a major challenge for health
care and social services, for society and for the persons
affected [1]. These individuals often have to make im-
portant day-to-day adjustments as a result of disability,
loss of income, and a declining quality of life [2,3]. It is
now recognized that primary care should be central to
the customized and effective management of CD [4,5],
and that innovative strategies targeting the current
organization of primary care must be offered and evalu-
ated to better support the individuals affected [1], par-
ticularly the most vulnerable [6]. To meet the complex
needs of people with CD and to reduce societal conse-
quences, primary care must provide a range of services
that are interdisciplinary, person-centred and adjusted to
the individual’s current health conditions and character-
istics [7,8]. These services must also be oriented towards
self-management, where the people affected and their
families are called upon to play a greater role in the
management of their health [1,7,9].
A number people with CD require higher intensity
care because of personal characteristics that increase
their vulnerability. This applies especially to the socioe-
conomically disadvantaged [10,11] and to those who
present a comorbid mental health condition [12,13] or
multimorbidity (two or more CD) [13,14]. In addition to
a compromised quality of life and an increased risk of
social isolation, these individuals have problems comply-
ing with treatment, adopting healthy behaviours and
managing their health. This can result in increased ser-
vices use, like emergency department visits and hospita-
lizations [15,16]. Case management strategies could be
developed to address the vulnerability factors of frequent
users in order to prevent inequities in health care and
related costs [17].
In 2004, Family Medicine Groups (FMG) were imple-
mented by the ministère de la santé et des services
sociaux du Québec (Quebec’s ministry of health and so-
cial services) to improve accessibility, continuity, and co-
ordination of health care in Quebec [18]. A FMG is an
administrative arrangement for existing practices in
which primary care physicians who wish to participate
are grouped together to collaborate with nurses to offer
primary care services, including patient follow-up, health
promotion and preventive care, to a group of registered
patients. It offers access to care 10 hours a day, seven
days a week, through regular appointments, walk-in
clinics, home visits, and after-hours health coverage
using telephone hot-lines and emergency on-call ser-
vices. Family physicians who are members of FMG will
also work closely with other health care professionals in
community services centres, hospitals, community phar-
macies, etc., to complement the services they offer [19].Since the creation of these new care teams, FMG
nurses have already improved health education and the
accessibility and continuity of services for certain
patients, including those with diabetes, hypertension, on
anticoagulant treatment, etc. [20]. However, the most
vulnerable groups still pose major challenges in terms of
accessibility, delivery and coordination of primary care
[6]. The current work organization in FMG cannot opti-
mally respond to the multiple requests, the considerable
needs for self-management support of these patient
groups, and their frequent need to access various health
care resources [21], due, among other things, to lack of
coordination and integration of services.
A major consultation process conducted in 2010 on
the organization of CD services in the Saguenay-Lac-
Saint-Jean (SLSJ) region of Québec, identified two poten-
tial solutions to meet the challenges posed by vulnerable
patients with CD who frequently use hospital services
[22]: (1) Improve the coordination of services through
case management; and (2) Develop strategies to support
self-management. Some vulnerable patients could benefit
from closer monitoring by a case management nurse
[1,23] within a primary care team linked to other net-
work resources [1,6], and from self-management support
[2,6]. Case management programs for frequent users of
emergency departments have already been developed
or are being developed in the six Centre de santé et
de services sociaux (CSSS) (health and social services
centres) of the SLSJ region, including the two CSSS par-
ticipating in the project. Without being formally evalu-
ated, an assessment of their programs has brought to
light several positive points [24]: a significant decrease in
the number of frequent users of emergency services; a
high level of satisfaction among users and stakeholders;
and close cooperation between the program coordinator
and FMG nurses, who are considered essential partners
for patients with CD. Although promising, these case
management programs are often limited to the most ser-
ious cases due to capacity issues (50 persons per year at
the CSSS de Chicoutimi).
Faced with the growing needs and primary care chal-
lenges posed by increasingly vulnerable patients, the
Agence de santé et de services sociaux of the SLSJ region
(regional health and social services agency) and the two
partner CSSS proposed to implement similar and com-
plementary primary care interventions to allow vulner-
able patients with CD to benefit from case management
by a nurse within their FMG. The expansion of case
management within FMG will allow, together with the
case management services already offered by the CSSS,
a better response to the complex needs of vulnerable
patients, as well as improved services integration. Case
management will be performed in the primary care set-
ting, the FMG, ensuring a better collaboration between
Chouinard et al. BMC Health Services Research 2013, 13:49 Page 3 of 13
http://www.biomedcentral.com/1472-6963/13/49case management nurse and family doctor [25]. The
presence of a primary contact (FMG nurse), who is a
generalist and accessible, will promote the coordination
of patient care. As a result, the provision of case man-
agement can be adjusted in intensity and duration
based on patient needs, ensuring continuity and long-
term management.
The proposed intervention seeks to address many of
the challenges posed by CD, based on scientific evidence.
First, case management by primary care nurses has
proven to be effective for various CD [25-27]. In fact, a
key element of the effectiveness of an interdisciplinary
approach to CD for vulnerable primary care patients is
the use of a single caregiver (usually a nurse) to serve as
the main contact and to coordinate interventions be-
tween health care professionals and the services pro-
vided [28]. However, most studies on this issue have
been conducted in the context of a specific CD, which
does not correspond to the reality of the clientele cur-
rently managed in primary care. Moreover, the imple-
mentation of strategies for interdisciplinary patient
follow-up in the management of CD has to be evaluated
in its context.
To date, strategies to support self-management remain
poorly implemented in FMG. However, the positive
effects of self-management support groups, such as the
Stanford Chronic Disease Self-Management Program,
are widely recognized [29,30]. These strategies are
intended mostly for people who are in an early stage of
their disease [31]. A recent study in primary care con-
ducted in Ontario (Canada) showed a reduction in hos-
pital length of stay and an increase in patient satisfaction
with this type of self-management program [32]. An-
other study, in which vulnerable CD patients in primary
care were evaluated after a six-week intervention to sup-
port self-management, showed positive effects with re-
gard to patient self-management capacity, but there was
no comparison with a control group [33]. Very few stud-
ies have examined the implementation mechanisms and
the involvement of primary care professionals in such
self-management support programs [34]. The introduc-
tion of a self-management group support program in
FMG may inpsire more vulnerable people to participate
and attain positive outcomes [4].
Objectives
This project aims to document the implementation and
effects, within four FMG of the SLSJ region (Quebec,
Canada), of a pragmatic intervention involving case
management by a nurse to promote interdisciplinary
person-centred follow-up and group self-management
support for frequent users of hospital services (emer-
gency department visits and hospitalizations) with CD
(diabetes, cardiovascular diseases, respiratory diseases,musculoskeletal diseases and/or chronic pain). The
evaluation of the intervention has three objectives: (1) to
analyze the implementation of the intervention within
the existing structures of the four participating FMG in
order to: (a) Explain how the various contexts have influ-
enced the implementation of the intervention and the
observed effects, and (b) Identify elements that can be
assessed and applied in order to improve the intervention
and to promote its implementation in other FMG; (2) to
evaluate the proximal (self-efficacy, self-management
practices, health habits, activation and psychological dis-
tress) and intermediate (empowerment, quality of life
and health care use) effects of this intervention among
patients; (3) Conduct an economic analysis of the cost-
effectiveness and cost-benefit of the intervention.
Conceptual framework
The theoretical framework of the intervention is based
on two conceptual models. One supports the method-
ology of the clinical intervention, and the other supports
the implementation process, change management, and
knowledge transfer.
The first model is that of the UK National Health Ser-
vice on innovation in health care and social services for
people with CD [5]. This model incorporates the basic
principles of the Chronic Care Model [35], while also
drawing on lessons learned from US models, such as
that of Kaiser Permanente, with regard to the intensity
of care that is appropriate for the complex needs of
patients [36], and of the Evercare model, with regard to
the use of case management nurses in primary care [37].
The goal is to improve the health and quality of life of
people with CD by providing personalized and ongoing
support, based on the best evidence in the field. This
model proposes the implementation of a case manage-
ment system for patients with complex needs by making
primary care a central part of the organization of ser-
vices. To achieve this, the model suggests a structured
approach that will allow for interaction between CSSS
partners and community resources in order to provide
integrated services. It also proposes the implementation
of self-management support practices.
The second model the Promoting Action on Research
Implementation in Health Services (PARiHS) [38,39].
According to this model, successful implementation
depends on the nature and type of evidence from previ-
ous studies, the results of the proposed study, the con-
text in which it is introduced, and how the process is
facilitated. The value of the evidence depends not only
on its scientific reliability, but also on the experience of
the professionals and partners, as well as on patient
preferences. The implementation of evidence into prac-
tice is achieved through a dialogue with knowledge
users and must take their views into consideration.
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than others, particularly where there are natural leaders.
Finally, this model emphasizes the importance of appro-
priate facilitation, including various strategies for man-




Stemming from the theoretical framework described
above, the components and activities of the intervention
are shown in the logic model presented in Figure 1. The
components of the intervention will include case man-
agement by FMG nurses and a self-management group
support program as described below.
Case management by FMG nurses
The first component of the intervention is the follow-
up offered under the case management process, which
is seen as a collaborative, dynamic and systematic ap-
proach to ensure and coordinate care and services for
a defined clientele based on interdisciplinary practice.
Here the nurse evaluates, plans, implements, coordi-
nates and prioritizes options and services according to
patient health needs, in close collaboration with the
involved partners [40]. The intervention focuses on
four main components: (1) A thorough evaluation of
patient needs and resources; (2) Establishment and
maintenance of a patient-centred, individualized ser-
vice plan (ISP); (3) Coordination of services among
partners; and (4) Self-management support for patients
and families [41].
The main duties and responsibilities of nurses in case
management will be to: (1) Evaluate the patient’s situ-
ation and needs and involve the family, with the patient’s
consent; (2) Identify which partners of the CSSS and of
the community network to involve; (3) Jointly plan pa-
tient follow-up by establishing an ISP with the part-
ners and with the active participation of the patients
and family — minimum of two ISP per patient: one to
initiate the intervention and the other approximately 3
months later; (4) Negotiate the services and defend the
rights and interests of the individual; (5) Coordinate care
and services; (6) Monitor the ISP application; (7) Educate
and support the person. The ISP formulation stage will
be oriented towards a self-management support ap-
proach that will emphasize the following: the patient’s
potential; setting objectives according to his or her
perspective; developing problem-solving skills; and
using the patient’s usual support system [42]. Home
visits by the nurse may be required, when justified —
as in the case of reduced mobility or if a home assess-
ment is needed — while avoiding overlap with home
support services already offered.The intervention will be implemented in each FMG by
two nurses. Given the expertise of the nurses already
working in the FMG and their established relationships
with the medical teams and partners (e.g., community
pharmacists), it is preferable that they implement the
intervention rather than nurses hired for this project.
This also promotes the sustainability of the intervention
in the participating FMG. Nurses selected to conduct
the intervention will receive five days of theory and
practical training specific to case management and self-
management support, provided by the Clinical Project
Coordinator (described in following paragraph). Family
doctors will be actively sought throughout the interven-
tion to: identify participating patients, problems and
intervention priorities, participate in ISP preparation
meetings (in person or by having shared their perspec-
tive with the nurse prior to the meeting), and provide
the medical components of ISP implementation. Part-
ners include the CSSS professionals identified based on
the needs of participants, such as psychosocial service
providers (e.g. social worker) currently involved in a
patient’s care, or additional professional resources spe-
cializing in CD management (nurse, nutritionist, etc.).
The partners also include community organizations (e.g.,
home care services), patient associations and community
pharmacists.
A Clinical Project Coordinator with experience in
case management will be hired to coordinate and fa-
cilitate the implementation of the intervention (in-
cluding change management). She will be responsible
for: (1) setting up the intervention (training of case
management nurses, development of materials and
practice tools, recruitment and support of lay (peer)
leaders for the self-management group support pro-
gram, organization of support groups, scoping of
organizations and community associations in the re-
gion and establishing the first contact to ensure their
cooperation, etc.), including the communication plan
to prepare participating FMG and all partners, in
order to facilitate change management; and (2) en-
suring the implementation and proper roll-out of the
intervention (maintaining an appropriate standardized
level of intervention and providing support for case
management nurses, etc.). The Clinical Project Co-
ordinator will be responsible for clinical governance
in coordinating care within the network of each
CSSS [43]. This clinical governance will allow the
Clinical Project Coordinator to establish the required
intervention treatment pathways, with the support of
the two primary care managers involved, as needed.
Self-management group support program
The second component of the intervention consists of
group meetings (10–12 participants) for self-management
Figure 1 Intervention logic model.
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Developed by the Stanford Patient Education Centre
(http://patienteducation.stanford.edu) to support people
living with chronic conditions, the standardized curricu-
lum, materials and program implementation, have made it
the most accessible program for clinical and research appli-
cations [44]. An estimated 30% of participants enrolled in
the project should agree to participate in this component,
based on past primary care experiences described in theliterature [32,33]. The self-management group support
program rests on the premise that all patients with CD
have similar concerns. They have the capacity to take re-
sponsibility for managing several aspects of their CD
and will experience better results by building their sense
of self-efficacy and developing the required skills. This
model proposes a standardized six-week program with
interactive weekly group meetings led by two lay leaders,
who themselves have a CD. Twenty lay leaders (not
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the participating FMG practices and patient associations
through a variety of media. Interviews will be conducted
to ensure these volunteers are interested and able
to provide this program. Two certified master trainers
from My Toolbox program (http://mytoolbox.mcgill.ca) at
McGill University will train lay leaders according to the
Standard four-day training program. These lay leaders will
conduct a complete simulation exercise with volunteer
patients from their FMG to familiarize themselves with,
and standardize, the process before conducting meetings
with study participants. Two sessions of the self-
management group support program will be implemented
in each FMG. These meetings will take place at different
times, depending on the availability of participants.
Evaluation design
The evaluation of the intervention is based on a mixed
design of complex health intervention evaluations [45].
It focuses on three combined strategies based on the tar-
geted objectives and a pragmatic vision of the evaluation.
These three strategies: the implementation analysis, the
evaluation of the effects and the economic analysis will
be described separately. The methodological decisions
regarding patient selection, the implementation of the
intervention and the intervention modalities were made
in accordance with the established FMG practices to en-
sure the intervention meets their needs, and take into
account the organization of services.
Implementation analysis
This analysis will be based on two approaches: a realis-
tic evaluation and a practical participatory approach.
Consistent with the PARiHS conceptual framework, a
realistic evaluation will help explain how different
FMG, presenting a variety of practice environments
from various perspectives, influence the implementation
and the effects observed [46]. The realistic evaluation
approach — described as pragmatic — recognizes that
any outcome of an intervention results from the inter-
action between this intervention and its context [46]. It
aims to highlight the underlying mechanisms and their
performance under certain conditions. It recognizes
that the outcomes are found not only in the patients
but also in the stakeholders and organizations involved
[47]. The three key questions of realistic evaluation are:
(1) What has been implemented and why? (2) What
were the obstacles/challenges and what were the facili-
tating conditions? (3) What explains the successes or
failures (mechanisms)? The participatory approach will
help identify the practical elements to be considered to
improve the intervention and promote its implementa-
tion in other FMG [48]. The parameters to be evaluated
have been identified to describe in detail the context (C),the intervention and its action mechanisms (I), and the
effects of the intervention (E) on stakeholders and orga-
nizations, both qualitatively and quantitatively (Table 1).
Data collection strategies
A multiple-case study [49] will be performed with mul-
tiple sources of information. Such a strategy is particu-
larly appropriate for analyzing the context and the
mechanisms involved [50,51]. Each FMG will be consid-
ered a case with its own context, and will include its
interactions with partners. This study will be conducted
with a multifaceted approach before, during and after the
intervention. As described in Table 1, four categories of
key informants will be interviewed: (1) FMG stakeholders
(doctors/nurses); (2) managers (FMG/CSSS); (3) partici-
pating patients and their families; (4) identified partners
of case management (CSSS professionals, representatives
of community organizations and community pharma-
cists), as well as volunteer leaders of self-management
groups. Four strategies for collecting data will be used:
(1) focus groups; (2) individual interviews; (3) review of
documents produced during the implementation of the
intervention, (4) an intervention fidelity checklist. Inter-
view guides with open-ended questions that are adapted
to each category of key informants will be developed and
validated by implementation evaluation experts.
The pre-implementation phase will describe the con-
text of the intervention regarding: (1) the characteristics
of the environment (contextual factors); (2) the oper-
ation and integration of existing services, as well as par-
ticipant satisfaction; (3) the issues related to the
implementation as identified through group discussions.
Focus groups will involve FMG doctors (n = 6, one
group per FMG), patients and their families (n = 4
patients, one group per FMG; n = 4 family members,
one group per FMG) and partners considered to be key
participants (n = 4). Individual interviews will be con-
ducted with FMG and CSSS managers (n = 6) and FMG
nurses (n = 8).
The implementation phase will identify the changes in
FMG processes (mechanisms) and the integration of ser-
vices mid-way through the implementation in addition
to learning about the obstacles and challenges encoun-
tered, as reported through focus groups with FMG sta-
keholders (n = 6) and obtained from individual
interviews with FMG and CSSS managers (n = 6). Docu-
mentation from meetings of the advisory committee and
from meetings between the Clinical Project Coordinator
and nurses or managers, etc., will be obtained and ana-
lyzed in order to identify obstacles and challenges, and
adjustments made along the way. An evaluation of the
fidelity of the intervention will be conducted to docu-
ment the degree to which the intervention was imple-
mented; this will vary with the needs of participating
Table 1 Parameters of the implementation evaluation
Parameters evaluated FMG stakeholders Managers Patients/ Family Partners Other sources
Pre-implementation phase
Description of practice settings (contextual factors) (C) FG-II II FG FG
Description of the current processes, patient integration and
satisfaction (C)
FG-II II FG FG
Issues related to the implementation (C) FG-II II FG FG
Implementation phase
Evolution of the processes and integration FG II DR
Identification of problems and failures (C) FG II
Fidelity of the intervention (I) IFC
Post-implementation phase
Opinion about the implementation process (C) FG-II II FG FG
Identification of obstacles and facilitating elements (C) FG-II II FG FG
Description of the impact on stakeholders/organizations (E) FG-II II FG FG
Satisfaction with the intervention (E) DG-II II DG DG
C: Context; I: Intervention; E: Effects.
FG: Focus group; II: Individual interview; DR: Documentation review; IFC: Intervention fidelity checklist.
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the evaluation for participating patients using a standar-
dized checklist that includes the case management cri-
teria and follow-up parameters, the details of ISP, the
number of interdisciplinary meetings, the partners called
upon and their involvement, and the number of self-
management support meetings. These reports will help
determine whether the interventions have conformed to
the original study model.
The post-implementation phase will describe the imple-
mentation process, the obstacles and enabling factors, the
effects of the intervention on stakeholders/organizations,
and the satisfaction of key players. This will be
accomplished through focus groups with FMG physi-
cians (n = 6), patients and their families (n = 8) and
partners considered key informants (n = 4), and indi-
vidual interviews with FMG and CSSS managers (n = 6)
and with FMG nurses (n = 8).
Data analysis plan
Data collected from the key stakeholders will be analyzed
in three steps according to a qualitative content analysis
procedure to identify emerging themes and trends: cod-
ing, sorting of documentation by content, and analysis.
Driven by the data, inferences will be drawn and infor-
mation units will be compared [53]. This content analysis
will be performed using NVivo software (Version 9) for
data from individual and group interviews. In addition to
seeking to reveal the themes that are specific to each
element of the implementation evaluation (context, inter-
vention, mechanisms of action, impact), the analysis at
this stage aims to: (1) explain how different contexts have
influenced the implementation of the intervention andthe observed effects; and (2) identify elements to be con-
sidered in order to improve the intervention and pro-
mote its implementation in the other FMG [50]. The
scientific rigour of this approach will be assured by
recognized qualitative research strategies [54]. Credibility
(accuracy of the description of the phenomenon) will be
assured by open-ended questions, allowing participants
some latitude in what they want to reveal and by the tri-
angulation of informants. Reliability (accuracy with
which we account for various perceptions expressed by
participants) will be assured by data coding by at least
two members of the research team with expertise in dif-
ferent domains (triangulation of researchers). Validation
(confirmation of the analysis and interpretation) will be
assured through extensive documentation of the analysis
process. Transferability (transfer of the outcomes to
other settings or populations) will be assured by the
detailed description of the context and participants.
Evaluation of the effects
The evaluation of the effects on patients will be based
on a pragmatic randomized experimental design with
delayed intervention for the control group and mea-
surements taken before and after the intervention (at
six-month follow-up). This allows to evaluate interven-
tions in actual clinical settings to maximize their
generalizability [55]. Implementation analysis will
document how different contexts influenced the imple-
mentation and the observed effects. The before/after
experimental design is a robust method for observing
the potential effects of the intervention [56]. The de-
sign also includes an assessment regarding use of ser-
vices over a year in the experimental group.
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Targeted patients will be those described in the objec-
tives. The concept of vulnerability will be operationa-
lized by considering both the frequency of the CSSS care
use (emergency room visits and hospitalization) and pa-
tient vulnerability characteristics, based on the judgment
of the primary care team in the FMG. This combined
approach was proposed as a more favourable strategy for
patient identification for this kind of intervention, when
compared to using each one of these strategies in isola-
tion [57]. Steps to target the most vulnerable partici-
pants will include: 1) Presentation of the intervention to
FMG primary care physicians and nurses, 2) Delivery of
a computerized list (obtained using MAGIC Chronique
software by MédiaMed Technologies [58]) of the 300
most frequent users of CSSS services (emergency depart-
ment visits and hospitalizations) having at least one of
the targeted CD in each FMG. FMG professionals will
then identify the 100 patients they believe will benefit
most from the intervention described. The software used
for patient identification will serve as a system to sup-
port decision-making for primary care teams who did
not have access to this kind of information up till now.
After verifying patient eligibility and obtaining their
consent, participants will be allocated to one of two
groups (experimental or control) according to a
three-stage randomization process [59]: (1) gener-
ation of the patient allocation sequence using a sim-
ple randomization procedure; (2) allocation blinding
(sequentially numbered and sealed in opaque envel-
opes); (3) assignment of participants by opening the
envelopes at the time of recruitment. The experimen-
tal group will consist of a sample of 50 patients in
each of the four FMG (n = 200). These patients will
receive the intervention for six months. Patients in
the control group (n = 200) will receive the usual
care for six months and then the same intervention
as the treatment group for the following six months
(waiting list control group) [60]. This is intended to
avoid the problem of demoralization of the control
group, in addition to ensuring fair treatment among
participants in both groups.
Measures
The variables defined within the logic model will be mea-
sured using instruments that are well known and have
been validated in studies similar to the one proposed.
The proximal outcomes, evaluated at T0 (recruitment
period), T1 (3 months) and T2 (6 months) for both
groups (see Table 2), will be: (1) self-efficacy measured
with the Self-Efficacy for Managing Chronic Disease scale
[61]; (2) self-management practices, with the Self-moni-
toring and Insight sub-scale of the health education im-
pact questionnaire (heiQ [62,63]; (3) health habits, usingthe questionnaire developed as part of the PRECISE
study [64]; (4) patient activation, with the Patient Activa-
tion Measure [65]; and (5) psychological distress, with
the Psychological Distress Scale [66].
Intermediate outcomes, evaluated at T0 and T2 (see
Table 2), will include: (1) empowerment, measured with
the heiQ scale [62]; (2) quality of life, measured with the
SF-12v2 scale [67]; and (3) the use of health services,
measured using clinical data from the CSSS (with Magic
Chronique software by MediaMed) for hospitalizations,
emergency room visits and CSSS services (e.g., psycho-
social services or specialized services related to the spe-
cific CD), and electronic data on visits with physicians
and nurses in the FMG.
A number of covariables will also be documented
(T0) to describe participant characteristics: (1) socioe-
conomic status with family income and patient percep-
tions of his or her economic situation; (2) social
isolation, measured with the social isolation subscale of
the Nottingham Health Profile [68]; (3) literacy, mea-
sured with the Newest Vital Sign [69]; (4) mental
health, measured with the Hospital Anxiety and Depres-
sion Scale (HADS) [70,71]; and (5) multimorbidity,
measured with the Disease Burden Morbidity Assess-
ment (DBMA) [72]. French versions are available for all
validated instruments. When selecting data collection
instruments, valid shorter versions were preferred to re-
duce completion time. Considering the circumstances
of the vulnerable clientele, questionnaires will be self-
administered in the presence of a research assistant
who will provide the required assistance to the partici-
pant, ranging from minimal supervision to reading all
the questions, if and when needed. If the patient cannot
travel, the questionnaires can be administered by tele-
phone or at the participant’s home.
The evaluation component will be conducted accord-
ing to the study plan described in Table 2.
Sample size and statistical power
When analyzing quantitative data, we must take into ac-
count that part of the effect is potentially associated with
each of the eight case management nurses. The intra-
nurse or intracluster correlation (ρ) is unknown, how-
ever, and is specific to each variable. On the other hand,
given that series of standardization measures will be
implemented to minimize nurse-specific effects, we an-
ticipate that the intracluster correlation will not be
higher than 0.10. Sample size was therefore calculated
using this maximal anticipated ρ-value. Results indicated
that a standardized effect size (ES) of 0.5 (qualified as
medium [73]) will be detectable with two groups of 200
participants (25 per nurse) for a two-tailed test with the
α level set at 0.05 and a power of 80% [74]. An ES of at
least this magnitude can be expected since it was
Table 2 Proposed study plan
Visit 1 Visit 21 Visit 3 Visit 4 T32
T0 T1 T2
Time from the start of the intervention −2 weeks 0 3 months 6 months 12 months
Verification of eligibility √
Informed consent √
Covariables: Socioeconomic level, social isolation, literacy, mental health and multimorbidity √
Proximal outcomes: Personal self-efficacy, self-management practices, lifestyles, activation and
psychological distress
√ √ √
Intermediate outcomes: Empowerment, quality of life and use of services √ √ √
1 Visit 2 will mark the beginning of the intervention. This will be two weeks after randomization for the experimental group and 6 months after randomization for
the control group.
2 For the experimental group and use of services only.
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data from the CSSS de Chicoutimi. An ES of at least 0.5
also represents the clinically significant effect needed to
justify the pragmatic integration of the intervention into
the services already provided. For example, in the case
of patient empowerment, the ability to detect an ES of
0.5 translates into the capacity to detect any difference
of at least half a point within different domains of the
heiQ, since the overall standard deviation is about 1
point [76]. The detection of smaller differences is irrele-
vant since it is not clinically significant.
Data analysis plan
All statistical analyses will be performed based on an
intent-to-treat principle. We will first describe the charac-
teristics of participants in each group, using means and
standard deviations (continuous variables) or percentages
(categorical variables). The groups will be compared at
baseline (T0) using Student’s T test or the Chi-square test.
Wherever possible, comparisons will be made between
patients who agreed to participate in either phase of the
study and those who refused, in order to document biases
related to refusals. For outcome indicators at 3 months
(self-efficacy, self-management practices, health habits, acti-
vation and psychological distress), groups will be compared
at T1 using analysis of covariance adjusted for T0 scores.
For indicators measured at six months (empowerment,
quality of life and use of care), repeated measures analysis
of variance will compare change over time in the two
groups. In all cases, if the groups initially differ with regard
to certain characteristics despite randomization, analysis
will be adjusted to take into account the relevant variables.
In addition, if a nurse effect is present (non-null intracluster
correlation), despite efforts at standardization, multi-level
analysis will be conducted to take this into account.
Economic analysis
The economic analysis of the intervention will focus on
a cost-effectiveness and a cost-benefit analysis. Theimplemented intervention and the usual care will be
compared in each of these analyses.
The cost-effectiveness analysis (CEA) will compare the
relative costs invested and effects of implemented inter-
vention and usual care. On the other hand, the cost-
benefit analysis will indicate the savings per dollar
invested in the implemented intervention in terms of the
benefit/cost ratio. Benefits will be assessed by assigning
a monetary value to the effects. Because of the ethical
and methodological problems in the assignment of a
monetary value to quality of life, morbidity and mortality
[77,78], the cost-benefit analysis will be based on a prag-
matic approach; it will focus on the savings gained in re-
lation to the reduction of health care use due to the
implemented intervention.
Stages of data acquisition and analysis
(1) Cost analysis. Cost analysis will be performed from
an organizational perspective; that is, only costs related
to the FMG and CSSS will be outlined. The costs of
the intervention and of usual care will be identified. For
the experimental group, the average nurse’s salary for
the time devoted to intervention will be obtained (aver-
age cost per patient). The data on services obtained
from the CSSS (emergency visits, hospitalizations, etc.)
and from the FMG (excluding management of cases
already included in the calculation) during the six-
month follow-up will also be obtained and their monet-
ary value will be estimated, using the average cost per
patient for both groups. (2) Measurement of effective-
ness. Data collected as part of the impact evaluation
(intermediate outcomes) will be used to document the
effects of the intervention on empowerment, quality of
life, and use of services (emergency visits, hospitaliza-
tions, other CSSS services and FMG services). The
effects will be measured in terms of the empowerment
gained, quality of life gained, and, the reduction in use
of services. (3) Efficiency analysis. Costs and effects
will be compared, in order to identify whether the
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ness at lower cost. Incremental cost-effectiveness ratios
(ICER = Δ Effectiveness/Δ Costs) will be calculated.
This component will address the following three ques-
tions: (1) How much does it cost to improve empower-
ment? (2) How much does it cost to improve quality of
life? (3) How much does it cost to decrease use of CSSS
or FMG services? (4) Cost-benefit analysis. A cost-
benefit analysis will be performed if a reduction in the
use of services is documented (see power calculation in
“sample size and statistical power” section presented
previously). The cost differential of the cost of services
avoided, related to a reduction in the use of services for
the number of patients surveyed (Δ benefits), will be
compared to the cost differential of the intervention
and the usual care (Δ costs) so as to assess whether
the new intervention is cost-effective. We will calcu-
late the gain per dollar invested in the intervention by
estimating the Δ benefit/Δ cost ratio. If this ratio is
greater than 1, a gain will be indicated; otherwise, a
break-even point will be estimated by evaluating the
minimum cost at which the intervention will become
cost-effective. This analysis would also estimate the
caseload for obtaining a break-even point and for
identifying the profile of patients for whom the inter-
vention was more cost-effective. (5) Sensitivity ana-
lysis. Since many uncertainties are generally present
in the economic and effectiveness data, it will be im-
portant to complete the analysis by: (1) identifying
and explaining the sources of uncertainty; and (2) per-
forming sensitivity analyses by varying the value of
specific parameters related to the sources of uncer-
tainty, in order to assess the robustness of outcomes
[77,79], and if necessary, to determine the break-even
point of the intervention.
Ethical considerations
This study was approved by the Research Ethics Board
(REB) of the CSSS de Chicoutimi for both CSSS. Informed
consent will be obtained from all participants. The six-
month wait for the intervention for the control group has a
negligible effect given the chronic nature of the conditions
for which the intervention is proposed. Specific consent will
be sought from each participating patient for access to their
administrative health data and its use by the parties
involved in the study. Confidentiality will be respected and
data security ensured according to the rules in force within
both CSSS and by the Research Ethics Board of the CSSS
de Chicoutimi. Any publication resulting from this research
will respect patient confidentiality.
Discussion
The integration of case management by nurses and of
self-management support groups into the FMG has thepotential to impact patients positively, as outlined in the
logic model. The long-term effects described therein can-
not be measured due to the program's short timeframe,
but may be confidently assumed from the evidence pro-
vided in the literature. FMG nurses will be able to continue
to offer the intervention in their FMG after the implemen-
tation of the intervention. The caseload numbers that pro-
vide an optimal cost-benefit and a positive outcome profile
for target patients will inform decision-makers and man-
agers on the human and financial resources required to
achieve optimal outcomes. In addition, decision-makers,
managers and health care professionals will be aware of the
factors to consider that favour the implementation of this
intervention in FMG and other CSSS of the region and
throughout Quebec.
Strengths and limitations
The study design will not allow us to determine the
individual effects of each component (case manage-
ment and self-management group support) of the
intervention. It was conceived in order to evaluate the
addition of the self-management component for some
patients who can benefit from it according to primary
care practitioners’ perspective. Independent applica-
tions for funding are planned in order to evaluate the
effects of each component in a near future. A contam-
ination bias could occur between the case manage-
ment nurses and the nurses involved with the patient
control group. Several precautions will be taken to
minimize this bias. First, no nurse will monitor both
experimental group and control group. Discussions
between nurses caring for the groups will be kept to a
minimum with respect to the intervention and the
new follow-up methods developed during the first six
months of implementation. The implementation ana-
lysis will shed a qualitative light on this phenomenon.
The presence of eight case management nurses raises
the possibility of a “cluster” effect at the analysis level,
which will be verified. However, this should be min-
imal since many precautions will be taken to reduce
it: proper training of eight case management nurses
to ensure standardization; the important role of the
Clinical Project Coordinator in maintaining a compar-
able level of intervention among the eight nurses;
regular discussions (every 1.5 months) among case
management nurses. Repeat surveys induce a learning
effect; however, the time-lapse between each survey
questionnaire will be sufficient for the effect to be
minimal. Regarding external validity, the pragmatic
nature of the effects evaluation favours generalization.
Analysis of the implementation process will identify
the factors to be considered and the conditions to be
put into place to support implementation of the inter-
vention in other Quebec FMG.
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